LISA HICHKAD: Open Payments
NPI 1386840841 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,827 in 141 payments from 28 companies in 2025. Trend: 2023 $2,671 · 2024 $3,495 · 2025 $2,827
Food & beverage: $2,827
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $435 |
| Amgen Inc. | 21 | $369 |
| Madrigal Pharmaceuticals | 8 | $185 |
| Corcept Therapeutics | 10 | $180 |
| Insulet Corporation | 7 | $169 |
| Tandem Diabetes Care, Inc. | 7 | $148 |
| Lilly USA, LLC | 12 | $146 |
| Novartis Pharmaceuticals Corporation | 8 | $139 |
| Ascendis Pharma Endocrinology Inc | 9 | $135 |
| SANOFI-AVENTIS U.S. LLC | 6 | $134 |
Products named: Ozempic, TEPEZZA, REZDIFFRA, Korlym, Omnipod, t:slim X2 Insulin Pump with Control-IQ, LEQVIO, Yorvipath.
Industry payments across GA — which companies pay providers there.
